UNIVERSITY OF TASMANIA
🇦🇺Australia
- Country
- 🇦🇺Australia
- Ownership
- -
- Established
- 1890-01-01
- Employees
- 1.8K
- Market Cap
- -
- Website
- https://www.utas.edu.au/
Clinical Trials
3
Active:0
Completed:1
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)TapTalkTest Project:Development of a Non-invasive Screening Test to Detect Risk of Alzheimer's Disease Pathology
- Conditions
- DementiaSpeech DisordersAlzheimer DiseaseMovement Abnormalities
- First Posted Date
- 2023-11-02
- Last Posted Date
- 2023-11-14
- Lead Sponsor
- University of Tasmania
- Target Recruit Count
- 1000
- Registration Number
- NCT06114914
- Locations
- 🇦🇺
University of Tasmania, Hobart, Tasmania, Australia
TAS Test: Online Motor-cognitive Tests for Early Detection of Alzheimer's Disease
Recruiting
- Conditions
- Age-related Cognitive DeclineAlzheimer DiseaseDementia
- First Posted Date
- 2022-01-18
- Last Posted Date
- 2023-10-30
- Lead Sponsor
- University of Tasmania
- Target Recruit Count
- 3000
- Registration Number
- NCT05194787
- Locations
- 🇦🇺
University of Tasmania, Hobart, Tasmania, Australia
The Impact of Problem-Based Learning (PBL) and Lecturing
Not Applicable
Completed
- Conditions
- Learning
- First Posted Date
- 2008-09-04
- Last Posted Date
- 2008-09-04
- Lead Sponsor
- University of Tasmania
- Registration Number
- NCT00747188
News
Metformin Shows Promise in Reducing Knee Osteoarthritis Pain in Overweight Patients
A six-month clinical trial found that metformin, a common diabetes medication, significantly reduced knee osteoarthritis pain in overweight patients by 31.3 points compared to 18.9 points in the placebo group.